Geng Zong1, Xingwang Ye, Liang Sun, Huaixing Li, Zhijie Yu, Frank B Hu, Qi Sun, Xu Lin. 1. Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, and Graduate University of the Chinese Academy of Sciences, Shanghai, China.
Abstract
BACKGROUND: Palmitoleic acid has been shown to regulate adipokine expression and systemic metabolic homeostasis in animal studies. However, its association with human metabolic diseases remains controversial. OBJECTIVE: We aimed to investigate associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and metabolic syndrome (MetS) in a Chinese population. DESIGN: Erythrocyte fatty acids were measured in a population-based sample of 3107 men and women aged 50-70 y, for whom plasma glucose, insulin, lipid profile, adiponectin, retinol binding protein 4 (RBP-4), plasminogen activator inhibitor type 1, and high-sensitivity C-reactive protein (hsCRP) were measured. MetS was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans. RESULTS: The mean (±SD) erythrocyte palmitoleic acid value was 0.41 ± 0.20% of total fatty acids. Palmitoleic acid was positively correlated with RBP-4 (r = 0.14, P < 0.001) and inversely correlated with adiponectin (r = -0.15, P < 0.001). After multivariable adjustment, palmitoleic acid was strongly associated with MetS and its components. ORs (95% CIs) for comparisons of extreme quartiles of palmitoleic acid were 3.50 (2.66, 4.59) for MetS, 7.88 (5.90, 10.52) for hypertriglyceridemia, 2.13 (1.66, 2.72) for reduced HDL cholesterol, 1.99 (1.60, 2.48) for central obesity, and 1.86 (1.41, 2.44) for elevated blood pressure (all P < 0.001). Further control for adipokines and hsCRP abolished the association of palmitoleic acid with central obesity but not with other MetS components. CONCLUSION: Erythrocyte palmitoleic acid is associated with an adverse profile of adipokines and inflammatory markers and an increased risk of MetS in this Chinese population.
BACKGROUND:Palmitoleic acid has been shown to regulate adipokine expression and systemic metabolic homeostasis in animal studies. However, its association with human metabolic diseases remains controversial. OBJECTIVE: We aimed to investigate associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and metabolic syndrome (MetS) in a Chinese population. DESIGN:Erythrocyte fatty acids were measured in a population-based sample of 3107 men and women aged 50-70 y, for whom plasma glucose, insulin, lipid profile, adiponectin, retinol binding protein 4 (RBP-4), plasminogen activator inhibitor type 1, and high-sensitivity C-reactive protein (hsCRP) were measured. MetS was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans. RESULTS: The mean (±SD) erythrocyte palmitoleic acid value was 0.41 ± 0.20% of total fatty acids. Palmitoleic acid was positively correlated with RBP-4 (r = 0.14, P < 0.001) and inversely correlated with adiponectin (r = -0.15, P < 0.001). After multivariable adjustment, palmitoleic acid was strongly associated with MetS and its components. ORs (95% CIs) for comparisons of extreme quartiles of palmitoleic acid were 3.50 (2.66, 4.59) for MetS, 7.88 (5.90, 10.52) for hypertriglyceridemia, 2.13 (1.66, 2.72) for reduced HDL cholesterol, 1.99 (1.60, 2.48) for central obesity, and 1.86 (1.41, 2.44) for elevated blood pressure (all P < 0.001). Further control for adipokines and hsCRP abolished the association of palmitoleic acid with central obesity but not with other MetS components. CONCLUSION: Erythrocyte palmitoleic acid is associated with an adverse profile of adipokines and inflammatory markers and an increased risk of MetS in this Chinese population.
Authors: F Cambien; J M Warnet; V Vernier; P Ducimetière; A Jacqueson; C Flament; G Orssaud; J L Richard; J R Claude Journal: Am J Epidemiol Date: 1988-01 Impact factor: 4.897
Authors: Zhijie Yu; Xingwang Ye; Jing Wang; Qibin Qi; Oscar H Franco; Kirsten L Rennie; An Pan; Huaixing Li; Yong Liu; Frank B Hu; Xu Lin Journal: Circulation Date: 2009-06-01 Impact factor: 29.690
Authors: A Perez-Cornago; L Brennan; I Ibero-Baraibar; H H M Hermsdorff; A O'Gorman; M A Zulet; J Alfredo Martínez Journal: J Physiol Biochem Date: 2014-01-09 Impact factor: 4.158
Authors: Maude Perreault; Kaitlin Roke; Alaa Badawi; Daiva E Nielsen; Salma A Abdelmagid; Ahmed El-Sohemy; David W L Ma; David M Mutch Journal: Lipids Date: 2013-12-15 Impact factor: 1.880
Authors: Yiwei Ma; Liang Sun; Jun Li; Yao Hu; Zhenji Gan; Geng Zong; He Zheng; Qianlu Jin; Huaixing Li; Frank B Hu; Rong Zeng; Qi Sun; Xu Lin Journal: J Lipid Res Date: 2018-12-14 Impact factor: 5.922
Authors: C Austin Pickens; Ami Lane-Elliot; Sarah S Comstock; Jenifer I Fenton Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-31 Impact factor: 4.254
Authors: C Austin Pickens; Lorraine M Sordillo; Sarah S Comstock; William S Harris; Kari Hortos; Bruce Kovan; Jenifer I Fenton Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2014-12-10 Impact factor: 4.006
Authors: Yao Hu; Huaixing Li; Ling Lu; Ani Manichaikul; Jingwen Zhu; Yii-Der I Chen; Liang Sun; Shuang Liang; David S Siscovick; Lyn M Steffen; Michael Y Tsai; Stephen S Rich; Rozenn N Lemaitre; Xu Lin Journal: Hum Mol Genet Date: 2016-01-06 Impact factor: 6.150